search icon
search icon
Flag Arrow Down
Română
Română
Magyar
Magyar
English
English
Français
Français
Deutsch
Deutsch
Italiano
Italiano
Español
Español
Русский
Русский
日本語
日本語
中国人
中国人

Change Language

arrow down
  • Română
    Română
  • Magyar
    Magyar
  • English
    English
  • Français
    Français
  • Deutsch
    Deutsch
  • Italiano
    Italiano
  • Español
    Español
  • Русский
    Русский
  • 日本語
    日本語
  • 中国人
    中国人
Sections
  • News
  • Exclusive
  • INSCOP Surveys
  • Podcast
  • EU
  • Diaspora
  • Republic of Moldova
  • Politics
  • Economy
  • Current Affairs
  • International
  • Sport
  • Health
  • Education
  • IT&C knowledge
  • Arts & Lifestyle
  • Opinions
  • Elections 2025
  • Environment
About Us
Contact
Privacy policy
Terms and conditions
Quickly scroll through news digests and see how they are covered in different publications!
  • News
  • Exclusive
    • INSCOP Surveys
    • Podcast
    • EU
    • Diaspora
    • Republic of Moldova
    • Politics
    • Economy
    • Current Affairs
    • International
    • Sport
    • Health
    • Education
    • IT&C knowledge
    • Arts & Lifestyle
    • Opinions
    • Elections 2025
    • Environment
120 new news items in the last 24 hours
  1. Home
  2. Health

A drug to treat early-stage Alzheimer's, donanemab, has received a positive opinion from the EMA and is close to authorization in the European Union.

Cristina Petrache
whatsapp
facebook
linkedin
x
copy-link copy-link
27 July 2025, 13:08
main event image
Health
Foto unsplash.com
google-preference

Always see our news on Google

Donanemab, a new drug developed by Eli Lilly for the treatment of early forms of Alzheimer's disease, has received a favorable opinion from the EMA committee, recommending its authorization. The drug, which is intended for patients who are non-carriers or heterozygous for apolipoprotein E ε4, has been shown in clinical trials to slow the progression of cognitive impairment. The drug will be available as an infusible solution, and common side effects include amyloid-associated imaging abnormalities and headache. The final authorization decision rests with the European Commission.

Sources

sursa imagine
Stirile ProTV
Un nou tratament pentru boala Alzheimer în stadii timpurii, aproape de autorizare în UE
sursa imagine
G4Media
Un medicament pentru tratamentul bolii Alzheimer în stadii timpurii, aproape de autorizare în UE
sursa imagine
News.ro
Un medicament pentru tratamentul bolii Alzheimer în stadii timpurii, aproape de autorizare în UE

Latest News

22:59

Two unvaccinated people from Pennsylvania have died from measles, marking the first time in 35 years that deaths from this cause have been recorded.

22:52

Mihailo Fedorov, former Minister of Defense, warns that Ukraine is losing the war against Russia and has a limited window to make strategic decisions.

22:45

Prime Minister Bolojan: The allocations and scholarships for students remain unchanged

22:37

23% progress in the modernization of DJ 102I Valea Doftanei – Brădet

22:33

Ilie Bolojan states that the PSD will be responsible for the non-adoption of the unitary salary law, warning about the financial pressures that will arise in its absence.

See more news

NEWS ON THE SAME TOPICS

event image
Health
WHO begins clinical study for an antiviral drug against Ebola
event image
International
WHO will launch next week in Congo clinical studies for two treatments against Ebola
event image
International
AstraZeneca announced the failure of a drug for a rare heart condition, causing a 9% drop in the company's shares.
event image
International
The first doses of an experimental antiviral are being urgently sent to France, Spain, and the Netherlands, following an outbreak of hantavirus on a cruise ship.
event image
EU
A project funded by the European Union is testing 100,000 children for the early detection of type 1 diabetes.
event image
Health
France will start partial reimbursement of treatments for obesity from June, thus becoming the first state in the EU to subsidize these medications.
app preview
Personalized news feed, AI-powered search, and notifications in a more interactive experience.
app preview app preview
treatment Alzheimer medically

Informat EU

main event image
EU
5 hours ago

European Union officials have been targeted by spearphishing cyberattacks, attributed to hackers allegedly supported by Russia.

Sources
imagine sursa
imagine sursa
imagine sursa
imagine sursa

Editor’s Recommendations

main event image
Current Affairs
6 hours ago

The director of Nuclearelectrica, Cosmin Ghiță, resigns from his position.

Sources
imagine sursa
imagine sursa
imagine sursa
imagine sursa
imagine sursa
+1
main event image
International
6 hours ago

CIA Director, John Ratcliffe, is said to have secretly arrived in Moscow aboard an American military plane.

Sources
imagine sursa
imagine sursa
imagine sursa
main event image
Current Affairs
2 hours ago

Wizz Air expresses the desire to discuss with the Government of Romania for the takeover of the internal network TAROM/ The national company categorizes the proposal as unrealistic

Sources
imagine sursa
imagine sursa
imagine sursa
app preview
Personalized news feed, AI-powered search, and notifications in a more interactive experience.
app preview
app store badge google play badge
  • News
  • Exclusive
  • INSCOP Surveys
  • Podcast
  • EU
  • Diaspora
  • Republic of Moldova
  • Politics
  • Economy
  • Current Affairs
  • International
  • Sport
  • Health
  • Education
  • IT&C knowledge
  • Arts & Lifestyle
  • Opinions
  • Elections 2025
  • Environment
  • About Us
  • Contact
Privacy policy
Cookies Policy
Terms and conditions
Open source licenses
All rights reserved Strategic Media Team SRL

Technology in partnership with

anpc-sal anpc-sol